Azor (amlodipine & olmesartan medoxomil), a prescription blood pressure medication, has recently been linked to a rare gastrointestinal disease called sprue-like enteropathy. On July 3, 2013, the U.S. Food & Drug Administration (FDA) announced that labels of Azor and other olmesartan-based hypertension medications would be updated with verbiage about enteropathy, whose symptoms include persistent diarrhea, weight loss, nausea and vomiting. This article discusses how patients with sprue-like enteropathy are treated.
Free Azor Lawsuit Evaluation: If you or a loved one was diagnosed with enteropathy after using Azor, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
Is There a Difference Between Enteropathy and Celiac Disease?
Manufactured by Daiichi Sankyo, Azor is a prescription angiotensin II receptor blocker (ARB) drug used to treat high blood pressure (hypertension). Olmesartan, the main active ingredient contained in Azor, has always been known to cause diarrhea, but after evaluating adverse event reports in the medical literature, FDA has also identified a link between Azor and sprue-like enteropathy.
True celiac sprue, which is also referred to as celiac disease or gluten-sensitive enteropathy, is a digestive tract disorder caused by an intolerance to gluten. When patients with celiac sprue consume gluten-containing foods, it causes damage to the mucosa of the intestines, destroying the intestinal villi and flattening the lining of the intestine, a process called intestinal villous atrophy. This results in the body’s inability to digest critical food nutrients. Symptoms of celiac sprue typically include varying degrees of diarrhea, flatulence and weight loss. Due to the immune response caused by celiac sprue, an immunoglobulin A anti-tissue transglutaminase antibody (IgA-tTG) test will come back positive. Symptoms of sprue-like enteropathy present much the same as celiac sprue, except that the IgA-tTG test will be negative.
Treatment for Sprue-Like Enteropathy
On July 3, 2013, FDA issued a press release stating that Azor and other olmesartan-containing blood pressure medications would have their warning labels updated to include information regarding enteropathy. According to the press release, onset of the disease can occur two years or more after patients start taking the drugs.
Nurses should be aware of the risk of sprue-like enteropathy, and assess patients treated with Azor for diarrhea and weight loss, and provide education about the disease’s symptoms. If the patient is experiencing chronic diarrhea and unusual weight loss, the problem should be reported to the prescriber immediately. If true celiac sprue is determined not to be the problem, Azor should be discontinued for another hypertension drug with fewer potential side effects.
Can I File an Azor Lawsuit?
Only a qualified attorney can determine whether you are eligible to file a lawsuit against Daiichi Sankyo, the maker of Azor, which is why we are currently offering free case evaluations. Simply fill out the confidential evaluation form below to contact our law firm now.
Most cases involving pharmaceuticals allege that a drug was sold with design, manufacturing, and/or marketing defects, which typically refers to a company’s failure to warn of a certain side effect. In the case of Azor, our attorneys suspect that patients may be able to take legal action in light of claims that Daiichi Sankyo failed to adequately warn doctors and patients about the risk of sprue-like enteropathy.
How Can Filing a Lawsuit Help Me?
By filing a lawsuit against the maker of Azor, you may be entitled to collect compensation for all current and future medical expenses related to the treatment of your enteropathy, as well as for damages for pain and suffering. Additionally, filing a lawsuit can help hold the drug’s manufacturer accountable for releasing an allegedly defective drug into the marketplace, and to discourage other pharmaceutical companies from engaging in similar conduct.
Do I have an Azor Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Azor lawsuits. We are handling individual litigation nationwide and currently accepting new Azor Enteropathy cases in all 50 states.
Free Azor Lawsuit Evaluation: If you or a loved one was diagnosed with enteropathy after taking Azor, you should contact our law firm immediately. You may be entitled to compensation by filing an Azor Suit and we can help.